TW255894B - - Google Patents

Info

Publication number
TW255894B
TW255894B TW082108775A TW82108775A TW255894B TW 255894 B TW255894 B TW 255894B TW 082108775 A TW082108775 A TW 082108775A TW 82108775 A TW82108775 A TW 82108775A TW 255894 B TW255894 B TW 255894B
Authority
TW
Taiwan
Application number
TW082108775A
Other languages
Chinese (zh)
Original Assignee
Fujisawa Yakusin Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929222291A external-priority patent/GB9222291D0/en
Priority claimed from GB939314495A external-priority patent/GB9314495D0/en
Application filed by Fujisawa Yakusin Kogyo Kk filed Critical Fujisawa Yakusin Kogyo Kk
Application granted granted Critical
Publication of TW255894B publication Critical patent/TW255894B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
TW082108775A 1992-10-23 1993-10-21 TW255894B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929222291A GB9222291D0 (en) 1992-10-23 1992-10-23 New cephem compounds
GB939314495A GB9314495D0 (en) 1993-07-12 1993-07-12 New cephem compounds

Publications (1)

Publication Number Publication Date
TW255894B true TW255894B (en) 1995-09-01

Family

ID=26301852

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082108775A TW255894B (en) 1992-10-23 1993-10-21

Country Status (9)

Country Link
EP (1) EP0665847A1 (en)
JP (1) JPH08502513A (en)
KR (1) KR950704331A (en)
CN (1) CN1144222A (en)
CA (1) CA2147609A1 (en)
IL (1) IL107359A0 (en)
MX (1) MX9306572A (en)
TW (1) TW255894B (en)
WO (1) WO1994010177A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69737382T2 (en) 1996-11-06 2007-10-31 Basilea Pharmaceutica Ag Vinyl-pyrrolidinone cephalosporin derivatives
TW415949B (en) * 1996-12-19 2000-12-21 Hoffmann La Roche Vinyl pyrrolidine cephalosporin derivatives with basic substituents
JP4100908B2 (en) 1999-07-30 2008-06-11 エーザイ・アール・アンド・ディー・マネジメント株式会社 Production method of basic antibiotics and inorganic acid salts and oxalate intermediates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4546101A (en) * 1982-09-10 1985-10-08 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds useful for treating infectious diseases in human being and animals and processes for preparation thereof
GB8519606D0 (en) * 1985-08-05 1985-09-11 Fujisawa Pharmaceutical Co 3 7-d substituted-3-cephem compounds
JPH0686463B2 (en) * 1988-07-01 1994-11-02 明治製菓株式会社 Novel cephem compound, its production method and antibacterial agent

Also Published As

Publication number Publication date
MX9306572A (en) 1994-04-29
EP0665847A1 (en) 1995-08-09
CA2147609A1 (en) 1994-05-11
JPH08502513A (en) 1996-03-19
KR950704331A (en) 1995-11-17
IL107359A0 (en) 1994-01-25
WO1994010177A1 (en) 1994-05-11
CN1144222A (en) 1997-03-05

Similar Documents

Publication Publication Date Title
DK0598561T3 (en)
DK0553875T3 (en)
TW267176B (en)
TW224450B (en)
DK0599160T3 (en)
TW232646B (en)
DK0596750T3 (en)
DK0574087T3 (en)
DK0554977T3 (en)
DK0553681T3 (en)
DK0564197T3 (en)
TW234198B (en)
DK0581726T3 (en)
TW255894B (en)
DK0576097T3 (en)
FR2686406B1 (en)
DK0590732T3 (en)
TW243419B (en)
IN175424B (en)
ECSDI920019S (en)
ECSDI920048S (en)
IN177882B (en)
IN175196B (en)
IN185889B (en)
IN185514B (en)